UK Ketamine Rehab Referrals Surge as Young Adults Face Severe Physical Harm
The drugs charity Kaleidoscope reports a twelvefold increase in ketamine treatment referrals in the UK over the last decade, with 112 people seeking inpatient detox at its Birchwood facility in 2026 alone. Most clients are aged 18 to 24, having started using the drug as early as age 13 or 14. Chronic use causes rapid physical deterioration, including bladder damage, kidney failure, and nasal collapse, often requiring incontinence pads. Traditional addiction services are struggling to adapt to these complex medical needs, prompting new research into specialized support models.
Key points
- Kaleidoscope’s Birchwood facility received 112 ketamine-related referrals in 2026, compared to just two in 2021.
- The majority of clients are aged 18 to 24, with some starting use as young as 13.
- Illicit ketamine use in the UK is estimated at 264,000 people aged 16 to 59 for 2024-25.
- Physical harms include bladder damage, kidney failure, memory issues, and nasal collapse from snorting.
- University of South Wales is researching specific support needs, noting that relapse causes faster physical harm than initial use.
Background
This story follows broader trends in synthetic drug crises and mental health support, but focuses specifically on the UK's ketamine epidemic. Unlike previous archive topics regarding tech support or AI companionship, this highlights a physical health crisis among young adults. The reclassification of ketamine as a Class B drug in 2014 did not prevent its widespread illicit use, which has surged due to low cost and accessibility.
Why it matters
The rapid physical decline experienced by young ketamine users challenges existing healthcare and addiction frameworks. Traditional services designed for older adults or alcohol dependence are ill-equipped for the complex medical presentations of this demographic. Without adapted interventions, young people face long-term disability and stigma, while the lack of data on recovery outcomes hampers effective policy and treatment development.
What to watch
Researchers at the University of South Wales and Kaleidoscope are developing tailored support models based on lived experience. Early intervention programs in schools and colleges are showing promise in reducing new cases, but long-term support for existing users remains critical. Understanding the reversibility of physical damage and preventing relapse are key priorities for future healthcare strategies.
Want the full story? Read the original reporting
Read on BBC